Earnings Preview | A 121x P/E Gamble: If Palantir's (PLTR.US) Guidance Is Not "Stunning Enough," the Stock Price May Fall Sharply

Note that Palantir (PLTR.US) will report its third-quarter 2026 earnings after the market close on Monday, November 2, Eastern Time. Against the backdrop of a string of large-cap tech earnings triggering selloffs and investors re-examining returns on artificial intelligence investments, this report is seen as the week's most important test of the "AI trade." Revenue expected to grow about 85%, earnings nearly double The latest market consensus shows analysts expect Palantir's third-quarter revenue of about US$2.18 billion, up about 85% year over year, with a forecast range of US$2.16 billion to US$2.26 billion; adjusted earnings per share of about US$0.41, nearly double the US$0.21 in the year-ago period, with a forecast range of US$0.38 to US$0.45. Analysts surveyed by FactSet expect slightly higher figures, with revenue of about US$2.22 billion and earnings per share of about US$0.42. For reference, the company's second-quarter revenue was US$1.94 billion and adjusted earnings per share were US$0.41, both beating market expectations. Over the past two years, Palantir has beaten Wall Street forecasts on both revenue and earnings almost every quarter, with an average earnings surprise of about 15% over the past four quarters. That repeated beat record has also raised the bar for this report. Full-year guidance is another key focus. In August, Palantir raised its full-year 2026 revenue forecast to US$8.15 billion to US$8.16 billion, corresponding to about 82% growth, and raised its full-year US commercial business growth guidance to at least 134%. The current market consensus has already reached about US$8.22 billion, above the company's guidance range. Management's prior third-quarter revenue guidance of US$2.16 billion to US$2.164 billion is already below current market expectations, meaning that "beating expectations and raising guidance again" has become almost a necessary condition for the stock price to stay strong. Commercial business growth is the core In this report, investors will focus on several operating metrics: first, the revenue growth rate of the US commercial business, which surged 149% year over year to US$764 million in the second quarter and was the focus of attention; whether it can maintain growth of around 140% after the base rises by about 30 percentage points this time will directly test the penetration speed of the enterprise AI platform (AIP); second, the US government business, where investors need to watch whether the pace of federal contract awards continues to recover; third, whether the international commercial business can reaccelerate as expected; fourth, earnings quality metrics, including the adjusted operating margin (62% in the second quarter), the Rule of 40 score and free cash flow performance. In addition, capital allocation has become a new topic. RBC Capital Markets counted that before the earnings report, investor questions about dividends, share buybacks and stock splits accounted for 46% of all weighted questions, up 30 percentage points from the previous quarter, reflecting that the market has begun to focus on how the company will use its cash reserves of about US$9 billion. Citi and JPMorgan are bullish, Morgan Stanley is cautious Ahead of the earnings report, a number of Wall Street institutions raised their expectations. Citi maintained its "Buy" rating and raised its target price to US$250 from US$245. Citi analysts said channel checks showed strong partner demand, especially in US federal business; one federal-sector specialist partner said its overall technology business grew more than 60% year over year, with Palantir one of the biggest beneficiaries, indicating the company has clearly recovered from the hit from last year's Department of Government Efficiency (DOGE) spending cuts. Citi expects US commercial business revenue growth to exceed 140%, international commercial business to reaccelerate, and US government business to also deliver double-digit growth above expectations, and expects the company to raise its full-year revenue growth guidance by another 10 percentage points or so. JPMorgan analyst Brian Essex initiated coverage of Palantir with an "Overweight" rating and added it to the "Positive Catalyst Watch List," with a December 2027 target price of US$262. He believes the focus of enterprise AI adoption is shifting from technology deployment to pursuing actual return on investment, and Palantir's platform can already genuinely transform customers' business processes, making it a relatively direct software beneficiary of this AI investment cycle. Morgan Stanley likewise sees strong channel momentum and a healthy demand environment, but gives only an "Equal-weight" rating with a target price of US$205, a relatively restrained stance. Guidance must be stunning, not merely excellent If the disagreement at the business level is merely a matter of being bullish versus more bullish, then the debate at the valuation level is the real undercurrent of this earnings report. Most analysts acknowledge that Palantir's current pricing has departed from conventional valuation frameworks. First, the numbers. Palantir's current forward price-to-earnings ratio is about 89 times, versus about 19 times for the S&P 500; calculated based on market consensus, its P/E is about 121 times on 2026 earnings and still as high as about 75 times even on 2027 expected earnings; enterprise value is about 61 times expected 2026 revenue. In a cross-sectional comparison, NVIDIA Corporation (NVDA.US), which is likewise at the center of the AI narrative, has a forward P/E of only around 30 times. Since its previous earnings report in August, Palantir's stock price has risen about 60% cumulatively, with valuation expansion even faster than the upward revisions to earnings expectations, meaning that a considerable part of the stock's gain comes from "faith top-ups" rather than fundamental delivery. The distribution of sell-side analysts' target prices itself exposes this awkwardness. Citi's US$250 and JPMorgan's US$262 bullish target prices are certainly eye-catching, but Morgan Stanley gives only a US$205 "Equal-weight" rating, and some institutions' conservative target prices were previously even below the current price. Analyst Future Stack Investment warned that Palantir's stock price gain has already outpaced earnings growth, and the valuation premium requires the company to continuously beat expectations on both revenue and margins, leaving "almost zero" room for error in execution. In other words, what the market is buying now is not Palantir's present, but a future it must deliver doubled year after year. This valuation structure determines the highly asymmetric reaction to earnings: if the company merely delivers an "excellent" report card, with revenue in line and guidance slightly raised, the stock price may instead fall, because all of that has already been priced in; only a "super-stunning" guidance far exceeding expectations, such as a substantial raise to the full-year revenue target and another step up in US commercial business growth, can drive the stock price higher. This earnings season has already repeatedly played out a similar script. Data from Jefferies Financial Group Inc. show that tech companies' shares fell an average of 3% the day after reporting results, the worst performance since the institution began tracking 12 years ago; the Nasdaq Composite Index fell 2% last week, its third consecutive weekly decline. The market's punishment for those falling short of elevated expectations is clearly heavier than its reward for those beating them. LSEG IBES data show that overall profits for about half of S&P 500 companies that have reported results are still up 31% year over year, indicating that corporate fundamentals are not bad; the crux of the decline is that expectations were set too high. For Palantir, whose valuation multiple is far above the broader market, this risk is further amplified. Some market observers have begun to flag signs of technical weakening, believing the stock price is showing signs of breaking below key support levels before the earnings report. For Palantir, the third-quarter revenue figure itself is only the starting point. US commercial business growth, government contract performance, the magnitude of the full-year guidance raise, and management's comments on shareholder returns will together determine whether this report is "proof of faith" or "the fuse for a valuation reversion." In a market that rewards only the "stunning," "very good" may be precisely the most dangerous answer.